New Approach to Detecting and Monitoring Renal Diseases in Nephrotic Syndrome

A recent study published in the New England Journal of Medicine and presented at the 61st ERA Congress in Stockholm has identified anti-nephrin autoantibodies as a reliable biomarker for monitoring renal diseases associated with nephrotic syndrome. This breakthrough could lead to more personalized treatment strategies for individuals with nephrotic syndrome, offering hope for better disease management.